{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:07:59Z","timestamp":1786118879373,"version":"build-2736575974"},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1097\/mjt.0b013e31804bfa6a","type":"journal-article","created":{"date-parts":[[2007,12,4]],"date-time":"2007-12-04T03:01:50Z","timestamp":1196737310000},"page":"555-560","source":"Crossref","is-referenced-by-count":4,"title":["Multiple Sclerosis and Natalizumab"],"prefix":"10.1097","volume":"14","author":[{"given":"Domenico","family":"Fiore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210202","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJMoa020696","article-title":"A controlled trial of Natalizumab for relapsing multiple sclerosis.","volume":"348","author":"Miller","year":"2003","journal-title":"New Engl J Med"},{"key":"R6-8-20210202","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00045391-200309000-00011","article-title":"Diagnosis and treatment of multiple sclerosis and amyotrophic lateral sclerosis: neuropathies from bordetella pertussis.","volume":"10","author":"Fiore","year":"2003","journal-title":"Am J Therapeut"},{"key":"R7-8-20210202","first-page":"61","article-title":"Malattie da B.","volume":"21","author":"Fiore","year":"2001","journal-title":"Pertussis nellUomo - EOS"},{"key":"R9-8-20210202","first-page":"54","article-title":"Gli Astrociti.","volume":"42","author":"Kimelberg","year":"1989","journal-title":"Scienze"},{"key":"R11-8-20210202","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1212\/WNL.47.6.1535","article-title":"Soluble intercellular adhesion molecule-1 in serum and cerebrospinal fluid of clinically active relapsing-remitting multiple sclerosis: Correlation with Gd-DTPA magnetic resonance imaging-enhancement and cerebrospinal fluid findings.","volume":"47","author":"Trojano","year":"1996","journal-title":"Neurology"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MJT.0b013e31804bfa6a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:56:02Z","timestamp":1786035362000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00045391-200711000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e31804bfa6a","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}